Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Vessel Prosthesis Implantation | 95 | 2024 | 1456 | 11.930 |
Why?
|
Endovascular Procedures | 96 | 2024 | 2219 | 9.870 |
Why?
|
Aortic Aneurysm, Thoracic | 57 | 2024 | 708 | 8.850 |
Why?
|
Aortic Aneurysm, Abdominal | 64 | 2024 | 1248 | 8.390 |
Why?
|
Blood Vessel Prosthesis | 66 | 2024 | 956 | 7.910 |
Why?
|
Prosthesis Design | 54 | 2024 | 2111 | 3.530 |
Why?
|
Stents | 45 | 2024 | 3191 | 3.410 |
Why?
|
Aortic Aneurysm | 19 | 2024 | 649 | 2.850 |
Why?
|
Spinal Cord Ischemia | 11 | 2024 | 94 | 2.730 |
Why?
|
Vascular Surgical Procedures | 22 | 2024 | 1506 | 2.470 |
Why?
|
Iliac Aneurysm | 8 | 2024 | 37 | 2.290 |
Why?
|
Aortic Diseases | 12 | 2022 | 741 | 1.760 |
Why?
|
Endoleak | 19 | 2024 | 111 | 1.710 |
Why?
|
Aortography | 31 | 2024 | 423 | 1.650 |
Why?
|
Iliac Artery | 11 | 2024 | 344 | 1.640 |
Why?
|
Aortic Rupture | 9 | 2024 | 321 | 1.620 |
Why?
|
Aorta, Thoracic | 10 | 2021 | 1109 | 1.430 |
Why?
|
Vascular Patency | 18 | 2024 | 914 | 1.400 |
Why?
|
Ohio | 22 | 2020 | 320 | 1.320 |
Why?
|
Aorta, Abdominal | 7 | 2023 | 626 | 1.220 |
Why?
|
Endarterectomy, Carotid | 10 | 2024 | 556 | 1.200 |
Why?
|
Treatment Outcome | 111 | 2024 | 65194 | 1.080 |
Why?
|
Postoperative Complications | 49 | 2024 | 15802 | 1.070 |
Why?
|
Time Factors | 81 | 2024 | 40097 | 1.040 |
Why?
|
Aneurysm | 7 | 2023 | 343 | 1.040 |
Why?
|
Renal Artery | 5 | 2024 | 355 | 0.960 |
Why?
|
Subclavian Artery | 4 | 2021 | 138 | 0.940 |
Why?
|
Arterial Occlusive Diseases | 11 | 2020 | 742 | 0.920 |
Why?
|
Angioplasty, Balloon | 6 | 2020 | 591 | 0.900 |
Why?
|
Risk Factors | 98 | 2024 | 74850 | 0.870 |
Why?
|
Graft Occlusion, Vascular | 8 | 2021 | 539 | 0.750 |
Why?
|
Risk Assessment | 49 | 2024 | 24275 | 0.690 |
Why?
|
Aged, 80 and over | 65 | 2024 | 59496 | 0.670 |
Why?
|
Peripheral Vascular Diseases | 5 | 2023 | 489 | 0.670 |
Why?
|
Databases, Factual | 21 | 2024 | 8060 | 0.650 |
Why?
|
Device Removal | 4 | 2018 | 643 | 0.640 |
Why?
|
Matrix Metalloproteinase 9 | 8 | 2012 | 636 | 0.640 |
Why?
|
Retrospective Studies | 81 | 2024 | 81537 | 0.630 |
Why?
|
Aged | 110 | 2024 | 171163 | 0.610 |
Why?
|
Angiotensin II | 3 | 2012 | 844 | 0.600 |
Why?
|
Congresses as Topic | 2 | 2020 | 811 | 0.590 |
Why?
|
Ehlers-Danlos Syndrome | 2 | 2016 | 94 | 0.590 |
Why?
|
Biomedical Research | 4 | 2022 | 3458 | 0.570 |
Why?
|
Carotid Stenosis | 7 | 2024 | 857 | 0.560 |
Why?
|
Vascular Diseases | 4 | 2022 | 1161 | 0.560 |
Why?
|
Prosthesis Failure | 8 | 2015 | 1194 | 0.540 |
Why?
|
Hypoalbuminemia | 1 | 2017 | 90 | 0.520 |
Why?
|
Reoperation | 18 | 2020 | 4308 | 0.510 |
Why?
|
Kaplan-Meier Estimate | 16 | 2017 | 6503 | 0.500 |
Why?
|
Retreatment | 6 | 2021 | 598 | 0.500 |
Why?
|
Aorta | 11 | 2023 | 2040 | 0.490 |
Why?
|
Humans | 181 | 2024 | 765926 | 0.480 |
Why?
|
Male | 130 | 2024 | 363815 | 0.460 |
Why?
|
Pelvis | 2 | 2017 | 737 | 0.420 |
Why?
|
Chi-Square Distribution | 12 | 2016 | 3430 | 0.420 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2012 | 462 | 0.420 |
Why?
|
Female | 120 | 2024 | 396141 | 0.410 |
Why?
|
Forecasting | 1 | 2021 | 2936 | 0.400 |
Why?
|
STAT1 Transcription Factor | 2 | 2011 | 340 | 0.390 |
Why?
|
Interleukin-5 | 1 | 2012 | 268 | 0.370 |
Why?
|
Femoral Artery | 3 | 2020 | 825 | 0.370 |
Why?
|
Urinary Retention | 2 | 2023 | 100 | 0.360 |
Why?
|
Apolipoproteins E | 3 | 2012 | 1459 | 0.360 |
Why?
|
STAT Transcription Factors | 1 | 2011 | 189 | 0.350 |
Why?
|
Education, Medical, Graduate | 3 | 2024 | 2419 | 0.350 |
Why?
|
Physicians, Women | 3 | 2022 | 516 | 0.340 |
Why?
|
Middle Aged | 77 | 2024 | 223016 | 0.330 |
Why?
|
Viscera | 1 | 2010 | 138 | 0.330 |
Why?
|
Ischemia | 4 | 2018 | 1901 | 0.320 |
Why?
|
Vascular Grafting | 3 | 2020 | 163 | 0.320 |
Why?
|
Lower Extremity | 5 | 2022 | 1219 | 0.310 |
Why?
|
Pancreatic Elastase | 4 | 2005 | 124 | 0.300 |
Why?
|
Laparotomy | 2 | 2020 | 459 | 0.290 |
Why?
|
Tomography, X-Ray Computed | 32 | 2024 | 20690 | 0.290 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2024 | 2769 | 0.280 |
Why?
|
Hematoma | 4 | 2022 | 765 | 0.280 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2004 | 0.280 |
Why?
|
Peripheral Arterial Disease | 4 | 2024 | 1308 | 0.280 |
Why?
|
Prospective Studies | 25 | 2024 | 54807 | 0.280 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2661 | 0.280 |
Why?
|
Societies, Medical | 2 | 2020 | 3953 | 0.270 |
Why?
|
Cardiology | 1 | 2018 | 1696 | 0.270 |
Why?
|
Vascular Malformations | 1 | 2012 | 470 | 0.270 |
Why?
|
Thrombosis | 7 | 2024 | 2955 | 0.260 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2006 | 59 | 0.260 |
Why?
|
Aortic Valve Insufficiency | 1 | 2010 | 575 | 0.260 |
Why?
|
Inguinal Canal | 1 | 2006 | 71 | 0.260 |
Why?
|
Coronary Artery Bypass | 3 | 2019 | 2188 | 0.250 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3109 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3231 | 0.250 |
Why?
|
Aneurysm, False | 2 | 2017 | 264 | 0.240 |
Why?
|
Calcium Channel Blockers | 1 | 2008 | 685 | 0.240 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1167 | 0.230 |
Why?
|
Fluoroscopy | 3 | 2022 | 945 | 0.230 |
Why?
|
Ileus | 1 | 2024 | 65 | 0.230 |
Why?
|
Pandemics | 3 | 2020 | 8721 | 0.220 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2005 | 323 | 0.220 |
Why?
|
Alloys | 1 | 2024 | 109 | 0.220 |
Why?
|
Venous Thrombosis | 3 | 2020 | 1319 | 0.220 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1886 | 0.220 |
Why?
|
Marfan Syndrome | 2 | 2023 | 237 | 0.220 |
Why?
|
Loeys-Dietz Syndrome | 1 | 2023 | 40 | 0.210 |
Why?
|
omega-N-Methylarginine | 2 | 2002 | 108 | 0.210 |
Why?
|
Spinal Cord Injuries | 2 | 2023 | 928 | 0.210 |
Why?
|
Feasibility Studies | 5 | 2024 | 5300 | 0.210 |
Why?
|
Splenic Artery | 1 | 2023 | 58 | 0.210 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2007 | 614 | 0.200 |
Why?
|
Thrombelastography | 1 | 2024 | 198 | 0.190 |
Why?
|
Treatment Failure | 6 | 2020 | 2653 | 0.190 |
Why?
|
United States | 29 | 2024 | 72909 | 0.190 |
Why?
|
Popliteal Artery | 3 | 2008 | 311 | 0.190 |
Why?
|
Patient Selection | 6 | 2024 | 4248 | 0.190 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15401 | 0.190 |
Why?
|
Anticoagulants | 4 | 2024 | 4856 | 0.190 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1513 | 0.180 |
Why?
|
Stroke | 7 | 2024 | 9739 | 0.180 |
Why?
|
Renin-Angiotensin System | 1 | 2005 | 736 | 0.180 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 848 | 0.180 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2017 | 1225 | 0.180 |
Why?
|
Mesenteric Veins | 1 | 2021 | 86 | 0.180 |
Why?
|
Ischemic Attack, Transient | 2 | 2024 | 871 | 0.180 |
Why?
|
Aortic Valve | 1 | 2010 | 1964 | 0.180 |
Why?
|
Thrombolytic Therapy | 3 | 2024 | 2050 | 0.180 |
Why?
|
Sex Factors | 8 | 2024 | 10611 | 0.170 |
Why?
|
Arteritis | 1 | 2002 | 160 | 0.170 |
Why?
|
Journal Impact Factor | 1 | 2022 | 157 | 0.170 |
Why?
|
Connective Tissue Diseases | 1 | 2023 | 284 | 0.170 |
Why?
|
Tunica Intima | 1 | 2002 | 455 | 0.170 |
Why?
|
Delphi Technique | 1 | 2024 | 893 | 0.170 |
Why?
|
Diverticulum | 1 | 2021 | 137 | 0.170 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2021 | 198 | 0.170 |
Why?
|
Hyperplasia | 2 | 2002 | 1142 | 0.170 |
Why?
|
Image Enhancement | 1 | 2010 | 2857 | 0.170 |
Why?
|
Imaging, Three-Dimensional | 5 | 2022 | 4037 | 0.170 |
Why?
|
Angiography | 4 | 2010 | 1589 | 0.160 |
Why?
|
Odds Ratio | 7 | 2017 | 9656 | 0.160 |
Why?
|
Venous Insufficiency | 1 | 2021 | 109 | 0.160 |
Why?
|
Menopause, Premature | 1 | 2020 | 124 | 0.160 |
Why?
|
Incidence | 9 | 2021 | 21513 | 0.160 |
Why?
|
Cytokines | 2 | 2012 | 7417 | 0.160 |
Why?
|
Hospital Mortality | 9 | 2023 | 5339 | 0.160 |
Why?
|
Mesenteric Vascular Occlusion | 2 | 2011 | 93 | 0.160 |
Why?
|
Brachial Artery | 1 | 2020 | 374 | 0.160 |
Why?
|
Blood Group Antigens | 1 | 2020 | 183 | 0.160 |
Why?
|
Multivariate Analysis | 7 | 2017 | 12059 | 0.150 |
Why?
|
Regional Health Planning | 1 | 2019 | 95 | 0.150 |
Why?
|
Authorship | 1 | 2022 | 289 | 0.150 |
Why?
|
Polytetrafluoroethylene | 1 | 1999 | 242 | 0.150 |
Why?
|
Sexual Harassment | 1 | 2019 | 82 | 0.150 |
Why?
|
Versicans | 1 | 2018 | 40 | 0.150 |
Why?
|
Intraoperative Care | 2 | 2020 | 768 | 0.150 |
Why?
|
Drainage | 1 | 2024 | 1181 | 0.150 |
Why?
|
Physician Executives | 1 | 2019 | 140 | 0.150 |
Why?
|
Ultrasonography, Doppler | 1 | 2020 | 462 | 0.150 |
Why?
|
Aggrecans | 1 | 2018 | 88 | 0.150 |
Why?
|
Professional Practice | 1 | 2020 | 314 | 0.150 |
Why?
|
Surgery Department, Hospital | 1 | 2019 | 170 | 0.150 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2022 | 445 | 0.150 |
Why?
|
RNA, Messenger | 11 | 2018 | 12768 | 0.150 |
Why?
|
Specialties, Surgical | 1 | 2022 | 390 | 0.140 |
Why?
|
Down-Regulation | 3 | 2017 | 2925 | 0.140 |
Why?
|
Clinical Competence | 3 | 2024 | 4855 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.140 |
Why?
|
Cultural Competency | 1 | 2020 | 303 | 0.140 |
Why?
|
Consensus | 2 | 2024 | 3202 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2012 | 1494 | 0.140 |
Why?
|
School Admission Criteria | 1 | 2018 | 106 | 0.140 |
Why?
|
Severity of Illness Index | 9 | 2021 | 15878 | 0.140 |
Why?
|
Hypotension | 1 | 2023 | 885 | 0.140 |
Why?
|
Ultrasonography, Interventional | 3 | 2010 | 1519 | 0.140 |
Why?
|
Catheterization, Peripheral | 1 | 2020 | 345 | 0.140 |
Why?
|
Regional Blood Flow | 2 | 2017 | 1479 | 0.140 |
Why?
|
Nitric Oxide | 3 | 2002 | 2141 | 0.140 |
Why?
|
Cultural Diversity | 1 | 2020 | 370 | 0.140 |
Why?
|
Occupational Exposure | 2 | 2020 | 1806 | 0.140 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6838 | 0.130 |
Why?
|
Collagen Type III | 1 | 2016 | 92 | 0.130 |
Why?
|
Workplace | 2 | 2020 | 873 | 0.130 |
Why?
|
Rats, Sprague-Dawley | 11 | 2012 | 8107 | 0.130 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3530 | 0.130 |
Why?
|
Length of Stay | 8 | 2023 | 6486 | 0.130 |
Why?
|
Clinical Trials as Topic | 5 | 2020 | 8037 | 0.130 |
Why?
|
Elephants | 1 | 2016 | 41 | 0.130 |
Why?
|
Atherosclerosis | 2 | 2010 | 3419 | 0.130 |
Why?
|
Lipoprotein(a) | 1 | 2020 | 488 | 0.120 |
Why?
|
Terminally Ill | 1 | 2017 | 240 | 0.120 |
Why?
|
Online Systems | 1 | 2016 | 181 | 0.120 |
Why?
|
Specialization | 1 | 2019 | 779 | 0.120 |
Why?
|
Angiography, Digital Subtraction | 3 | 2013 | 331 | 0.120 |
Why?
|
Fibrinolytic Agents | 1 | 2024 | 2076 | 0.120 |
Why?
|
Radiography, Interventional | 2 | 2013 | 1128 | 0.120 |
Why?
|
Patient Care | 1 | 2020 | 628 | 0.120 |
Why?
|
Hospitals, Teaching | 1 | 2019 | 1156 | 0.110 |
Why?
|
Inflammation | 2 | 2012 | 10843 | 0.110 |
Why?
|
Leg | 2 | 2008 | 1088 | 0.110 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3407 | 0.110 |
Why?
|
Anastomosis, Surgical | 3 | 2019 | 992 | 0.110 |
Why?
|
Foreign-Body Migration | 3 | 2013 | 219 | 0.110 |
Why?
|
Women's Health | 2 | 2020 | 2081 | 0.110 |
Why?
|
Aortitis | 1 | 2014 | 77 | 0.110 |
Why?
|
Nutrition Assessment | 1 | 2017 | 738 | 0.110 |
Why?
|
Pulmonary Artery | 1 | 2002 | 1937 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 8924 | 0.110 |
Why?
|
Operating Room Nursing | 1 | 2013 | 24 | 0.110 |
Why?
|
Mice, Knockout | 6 | 2018 | 14450 | 0.110 |
Why?
|
Acute Disease | 7 | 2021 | 7236 | 0.110 |
Why?
|
Leadership | 2 | 2020 | 1393 | 0.110 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12529 | 0.110 |
Why?
|
Acute Kidney Injury | 3 | 2023 | 1943 | 0.100 |
Why?
|
Vascular System Injuries | 1 | 2016 | 245 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2020 | 871 | 0.100 |
Why?
|
Peritoneal Cavity | 1 | 2012 | 135 | 0.100 |
Why?
|
Collateral Circulation | 1 | 2013 | 289 | 0.100 |
Why?
|
Pulmonary Embolism | 2 | 2004 | 2596 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2002 | 3716 | 0.100 |
Why?
|
Rats | 12 | 2012 | 23708 | 0.100 |
Why?
|
Vertebral Artery | 1 | 2013 | 185 | 0.100 |
Why?
|
Embolization, Therapeutic | 4 | 2016 | 1405 | 0.090 |
Why?
|
Celiac Artery | 3 | 2013 | 65 | 0.090 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2013 | 305 | 0.090 |
Why?
|
Internship and Residency | 2 | 2024 | 5945 | 0.090 |
Why?
|
Dilatation, Pathologic | 2 | 2010 | 527 | 0.090 |
Why?
|
Mesenteric Artery, Superior | 3 | 2013 | 95 | 0.090 |
Why?
|
Macrophages, Peritoneal | 1 | 2012 | 242 | 0.090 |
Why?
|
Comorbidity | 4 | 2021 | 10575 | 0.090 |
Why?
|
Carotid Artery Diseases | 2 | 2010 | 872 | 0.090 |
Why?
|
Chronic Disease | 8 | 2021 | 9351 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1257 | 0.090 |
Why?
|
Education, Medical | 2 | 2020 | 1744 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1463 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1225 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4111 | 0.090 |
Why?
|
STAT5 Transcription Factor | 1 | 2011 | 268 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2019 | 710 | 0.090 |
Why?
|
Spinal Cord | 1 | 2018 | 1786 | 0.090 |
Why?
|
Age Factors | 6 | 2021 | 18382 | 0.090 |
Why?
|
Nitric Oxide Synthase | 2 | 2004 | 911 | 0.080 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 350 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2010 | 6202 | 0.080 |
Why?
|
Phosphorylation | 2 | 2011 | 8279 | 0.080 |
Why?
|
Politics | 1 | 2016 | 821 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2017 | 1422 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1878 | 0.080 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 601 | 0.080 |
Why?
|
Animals | 19 | 2018 | 168735 | 0.080 |
Why?
|
Wound Healing | 1 | 2020 | 2794 | 0.080 |
Why?
|
Life Tables | 3 | 2010 | 366 | 0.080 |
Why?
|
Medical Informatics | 1 | 2016 | 743 | 0.080 |
Why?
|
Vasoconstrictor Agents | 1 | 2012 | 653 | 0.080 |
Why?
|
Interleukin-10 | 2 | 2012 | 1181 | 0.070 |
Why?
|
Registries | 6 | 2021 | 8346 | 0.070 |
Why?
|
Vasculitis | 1 | 2012 | 528 | 0.070 |
Why?
|
Medicine | 1 | 2016 | 944 | 0.070 |
Why?
|
Michigan | 2 | 2006 | 329 | 0.070 |
Why?
|
Radiation Dosage | 2 | 2013 | 1945 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3928 | 0.070 |
Why?
|
Patient Transfer | 1 | 2014 | 789 | 0.070 |
Why?
|
Mesenteric Artery, Inferior | 2 | 2008 | 15 | 0.070 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 871 | 0.070 |
Why?
|
Th1 Cells | 1 | 2012 | 1040 | 0.070 |
Why?
|
Operating Rooms | 1 | 2013 | 785 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3385 | 0.070 |
Why?
|
Th2 Cells | 1 | 2012 | 1074 | 0.070 |
Why?
|
Pilot Projects | 3 | 2024 | 8724 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3460 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2017 | 2100 | 0.070 |
Why?
|
Hospitals, Military | 1 | 2006 | 62 | 0.070 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2009 | 291 | 0.070 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18292 | 0.060 |
Why?
|
Hemodynamics | 2 | 2017 | 4186 | 0.060 |
Why?
|
Nitroso Compounds | 1 | 2006 | 70 | 0.060 |
Why?
|
Tissue Scaffolds | 1 | 2012 | 934 | 0.060 |
Why?
|
Prognosis | 5 | 2021 | 29890 | 0.060 |
Why?
|
Syndrome | 2 | 2014 | 3271 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2005 | 150 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 122 | 0.060 |
Why?
|
Adult | 18 | 2024 | 223088 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2012 | 3247 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 5 | 2016 | 18074 | 0.060 |
Why?
|
Phenotype | 4 | 2016 | 16714 | 0.060 |
Why?
|
L-Selectin | 1 | 2005 | 212 | 0.060 |
Why?
|
Carotid Artery, External | 1 | 2004 | 37 | 0.060 |
Why?
|
Stainless Steel | 1 | 2024 | 79 | 0.060 |
Why?
|
Catalase | 1 | 2005 | 214 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4712 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 5919 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2005 | 133 | 0.060 |
Why?
|
Learning Curve | 2 | 2017 | 232 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3908 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4563 | 0.060 |
Why?
|
Perfusion | 2 | 2005 | 1408 | 0.060 |
Why?
|
Algorithms | 2 | 2024 | 14064 | 0.060 |
Why?
|
Hospitals, University | 1 | 2006 | 573 | 0.060 |
Why?
|
Emergencies | 3 | 2016 | 1221 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3955 | 0.050 |
Why?
|
Hypolipidemic Agents | 1 | 2008 | 609 | 0.050 |
Why?
|
Thrombophlebitis | 2 | 2001 | 289 | 0.050 |
Why?
|
Hemorrhage | 2 | 2014 | 3466 | 0.050 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2004 | 139 | 0.050 |
Why?
|
Renal Insufficiency | 1 | 2009 | 810 | 0.050 |
Why?
|
Recovery of Function | 1 | 2013 | 2963 | 0.050 |
Why?
|
Hypertension | 1 | 2023 | 8616 | 0.050 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39228 | 0.050 |
Why?
|
Anesthesiology | 1 | 2013 | 1133 | 0.050 |
Why?
|
Cells, Cultured | 5 | 2012 | 18962 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3801 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4527 | 0.050 |
Why?
|
Popliteal Vein | 1 | 2002 | 43 | 0.050 |
Why?
|
Tissue Engineering | 1 | 2012 | 1857 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 656 | 0.050 |
Why?
|
Saphenous Vein | 2 | 2013 | 519 | 0.050 |
Why?
|
Platelet Function Tests | 1 | 2024 | 276 | 0.050 |
Why?
|
Recurrence | 3 | 2011 | 8492 | 0.050 |
Why?
|
Evidence-Based Medicine | 3 | 2010 | 3690 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 322 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2005 | 393 | 0.050 |
Why?
|
Gelatinases | 1 | 2002 | 93 | 0.050 |
Why?
|
Femoral Vein | 1 | 2002 | 156 | 0.050 |
Why?
|
Enzyme Precursors | 1 | 2002 | 164 | 0.050 |
Why?
|
Propensity Score | 2 | 2020 | 1971 | 0.050 |
Why?
|
Veins | 1 | 2006 | 768 | 0.050 |
Why?
|
Nitrites | 1 | 2002 | 156 | 0.050 |
Why?
|
Culture Techniques | 1 | 2002 | 515 | 0.050 |
Why?
|
Anesthesia, Local | 1 | 2024 | 276 | 0.050 |
Why?
|
Survival Rate | 6 | 2014 | 12822 | 0.050 |
Why?
|
Logistic Models | 4 | 2021 | 13273 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 2255 | 0.040 |
Why?
|
E-Selectin | 1 | 2003 | 576 | 0.040 |
Why?
|
Trauma Centers | 1 | 2006 | 950 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10810 | 0.040 |
Why?
|
P-Selectin | 1 | 2003 | 598 | 0.040 |
Why?
|
Tamoxifen | 1 | 2005 | 964 | 0.040 |
Why?
|
Mutation | 2 | 2016 | 30192 | 0.040 |
Why?
|
Myocardial Infarction | 4 | 2019 | 11508 | 0.040 |
Why?
|
Fibrin | 1 | 2003 | 514 | 0.040 |
Why?
|
Mice | 5 | 2012 | 81782 | 0.040 |
Why?
|
Molecular Weight | 1 | 2002 | 2160 | 0.040 |
Why?
|
Sclerotherapy | 1 | 2021 | 184 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6544 | 0.040 |
Why?
|
Platelet Aggregation | 1 | 2022 | 769 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2004 | 701 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2006 | 1470 | 0.040 |
Why?
|
Punctures | 1 | 2020 | 372 | 0.040 |
Why?
|
Urinary Catheterization | 1 | 2020 | 195 | 0.040 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 707 | 0.040 |
Why?
|
Reference Values | 1 | 2005 | 4909 | 0.040 |
Why?
|
Career Mobility | 1 | 2020 | 261 | 0.040 |
Why?
|
Patient Care Team | 1 | 2009 | 2515 | 0.040 |
Why?
|
Chemokines | 1 | 2002 | 956 | 0.040 |
Why?
|
Urodynamics | 1 | 2020 | 349 | 0.040 |
Why?
|
Kinetics | 1 | 2005 | 6273 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1120 | 0.040 |
Why?
|
Paraplegia | 1 | 2018 | 159 | 0.040 |
Why?
|
Tunica Media | 1 | 2018 | 107 | 0.040 |
Why?
|
Rehabilitation Centers | 1 | 2019 | 244 | 0.040 |
Why?
|
Ligation | 2 | 2013 | 445 | 0.040 |
Why?
|
Boston | 2 | 2020 | 9334 | 0.040 |
Why?
|
Upper Extremity | 1 | 2022 | 681 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2009 | 2504 | 0.030 |
Why?
|
Organizational Culture | 1 | 2020 | 513 | 0.030 |
Why?
|
Cohort Studies | 4 | 2023 | 41680 | 0.030 |
Why?
|
Advisory Committees | 1 | 2020 | 796 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6058 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2001 | 627 | 0.030 |
Why?
|
Survival Analysis | 2 | 1999 | 10086 | 0.030 |
Why?
|
Disease Progression | 3 | 2022 | 13614 | 0.030 |
Why?
|
Constriction, Pathologic | 2 | 2010 | 1102 | 0.030 |
Why?
|
Neutrophils | 2 | 2005 | 3769 | 0.030 |
Why?
|
NF-kappa B | 1 | 2004 | 2492 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 407 | 0.030 |
Why?
|
Prevalence | 2 | 2024 | 15828 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15645 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1435 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2120 | 0.030 |
Why?
|
Regional Medical Programs | 1 | 2014 | 64 | 0.030 |
Why?
|
Pedigree | 2 | 2013 | 4535 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6306 | 0.030 |
Why?
|
Sweden | 1 | 2017 | 1381 | 0.030 |
Why?
|
Warfarin | 1 | 2002 | 1494 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10727 | 0.030 |
Why?
|
Africa | 1 | 2016 | 725 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2019 | 1791 | 0.030 |
Why?
|
Thoracic Surgery | 1 | 2020 | 727 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2028 | 0.030 |
Why?
|
Postpartum Period | 1 | 2020 | 1195 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2864 | 0.030 |
Why?
|
Family Characteristics | 1 | 2018 | 1001 | 0.030 |
Why?
|
Protective Clothing | 1 | 2013 | 103 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2020 | 2426 | 0.030 |
Why?
|
Aneurysm, Ruptured | 1 | 1998 | 455 | 0.030 |
Why?
|
Heredity | 1 | 2013 | 149 | 0.030 |
Why?
|
Radiation Monitoring | 1 | 2013 | 106 | 0.030 |
Why?
|
Aspirin | 1 | 2024 | 3135 | 0.030 |
Why?
|
New Zealand | 1 | 2013 | 359 | 0.020 |
Why?
|
Chile | 1 | 2013 | 258 | 0.020 |
Why?
|
Medicare | 2 | 2020 | 6815 | 0.020 |
Why?
|
Mitochondria | 1 | 2005 | 3669 | 0.020 |
Why?
|
Blood Platelets | 1 | 2022 | 2464 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1729 | 0.020 |
Why?
|
Intestines | 1 | 2021 | 1906 | 0.020 |
Why?
|
Atrial Fibrillation | 1 | 2011 | 5186 | 0.020 |
Why?
|
Porosity | 1 | 2012 | 347 | 0.020 |
Why?
|
Publishing | 1 | 2019 | 836 | 0.020 |
Why?
|
Neoplasms | 1 | 2021 | 22340 | 0.020 |
Why?
|
Tensile Strength | 1 | 2012 | 332 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1169 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2563 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8882 | 0.020 |
Why?
|
Postmenopause | 1 | 2020 | 2517 | 0.020 |
Why?
|
Polyesters | 1 | 2012 | 373 | 0.020 |
Why?
|
Linear Models | 2 | 2011 | 5873 | 0.020 |
Why?
|
South Africa | 1 | 2016 | 1868 | 0.020 |
Why?
|
Embolectomy | 1 | 2011 | 130 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 30230 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2011 | 510 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2969 | 0.020 |
Why?
|
Radiation Protection | 1 | 2013 | 424 | 0.020 |
Why?
|
Apoptosis | 1 | 2005 | 9505 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1804 | 0.020 |
Why?
|
Contrast Media | 2 | 2013 | 5330 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2010 | 297 | 0.020 |
Why?
|
Respiratory Insufficiency | 2 | 2011 | 1241 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8522 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3490 | 0.020 |
Why?
|
Prosthesis-Related Infections | 1 | 2013 | 497 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3847 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3106 | 0.020 |
Why?
|
Tibial Arteries | 1 | 2008 | 60 | 0.020 |
Why?
|
Benchmarking | 1 | 2014 | 1055 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7423 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22327 | 0.020 |
Why?
|
Smoking | 1 | 2024 | 9082 | 0.020 |
Why?
|
Embolism | 1 | 2011 | 401 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14643 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2009 | 436 | 0.020 |
Why?
|
Databases as Topic | 1 | 2009 | 472 | 0.020 |
Why?
|
Occupational Health | 1 | 2013 | 812 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2005 | 11030 | 0.020 |
Why?
|
Catheterization | 2 | 2004 | 1426 | 0.020 |
Why?
|
Afghanistan | 1 | 2006 | 76 | 0.020 |
Why?
|
Iraq | 1 | 2006 | 93 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3430 | 0.020 |
Why?
|
Vietnam Conflict | 1 | 2006 | 100 | 0.020 |
Why?
|
Blotting, Western | 2 | 2005 | 5019 | 0.020 |
Why?
|
Thrombectomy | 1 | 2011 | 676 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2013 | 1181 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4085 | 0.020 |
Why?
|
Troponin T | 1 | 2011 | 785 | 0.020 |
Why?
|
Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
Caspase 9 | 1 | 2005 | 184 | 0.020 |
Why?
|
Phlebography | 1 | 2006 | 326 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1727 | 0.010 |
Why?
|
Technology Transfer | 1 | 2004 | 41 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 538 | 0.010 |
Why?
|
Postoperative Care | 1 | 2010 | 1475 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14745 | 0.010 |
Why?
|
Signal Transduction | 1 | 2007 | 23597 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 97 | 0.010 |
Why?
|
Observer Variation | 1 | 2010 | 2611 | 0.010 |
Why?
|
Caspase 3 | 1 | 2005 | 731 | 0.010 |
Why?
|
Anxiety | 1 | 2018 | 4669 | 0.010 |
Why?
|
Guanidines | 1 | 2004 | 194 | 0.010 |
Why?
|
Digestive System Surgical Procedures | 1 | 2008 | 581 | 0.010 |
Why?
|
Health Care Sector | 1 | 2004 | 196 | 0.010 |
Why?
|
Caspases | 1 | 2005 | 880 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2004 | 512 | 0.010 |
Why?
|
Biomedical Technology | 1 | 2004 | 210 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2543 | 0.010 |
Why?
|
Radiography | 2 | 2004 | 6941 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2003 | 273 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9525 | 0.010 |
Why?
|
Child | 3 | 2023 | 80568 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2012 | 22228 | 0.010 |
Why?
|
Adolescent | 3 | 2023 | 88811 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 2002 | 122 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2005 | 1072 | 0.010 |
Why?
|
Cell Count | 1 | 2005 | 1823 | 0.010 |
Why?
|
Calcinosis | 1 | 2010 | 1475 | 0.010 |
Why?
|
Young Adult | 2 | 2023 | 59857 | 0.010 |
Why?
|
Cytosol | 1 | 2004 | 885 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2003 | 791 | 0.010 |
Why?
|
Physicians | 1 | 2018 | 4591 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2004 | 1985 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2005 | 3583 | 0.010 |
Why?
|
Protein Precursors | 1 | 2004 | 1133 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1724 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1835 | 0.010 |
Why?
|
Carotid Artery Injuries | 1 | 1999 | 96 | 0.010 |
Why?
|
Tracheostomy | 1 | 2003 | 430 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2003 | 1605 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4055 | 0.010 |
Why?
|
History, 20th Century | 1 | 2006 | 2760 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26282 | 0.010 |
Why?
|
Microscopy | 1 | 2003 | 900 | 0.010 |
Why?
|
Fascia | 1 | 1998 | 143 | 0.010 |
Why?
|
Thigh | 1 | 1998 | 236 | 0.010 |
Why?
|
Compartment Syndromes | 1 | 1998 | 159 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4130 | 0.010 |
Why?
|
Ethanol | 1 | 2001 | 1325 | 0.010 |
Why?
|
Child, Preschool | 2 | 2009 | 42510 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2006 | 2513 | 0.010 |
Why?
|
Monocytes | 1 | 2003 | 2591 | 0.010 |
Why?
|
Gene Expression | 1 | 2005 | 7581 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1999 | 2863 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 20133 | 0.010 |
Why?
|
Ultrasonography | 1 | 2004 | 5987 | 0.010 |
Why?
|
Macrophages | 1 | 2005 | 5772 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4423 | 0.010 |
Why?
|
HIV Infections | 1 | 2016 | 17531 | 0.010 |
Why?
|
Anemia | 1 | 1998 | 1514 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11895 | 0.000 |
Why?
|